Identification of a Glucan-Associated Enolase as a Main Cell Wall Protein of Candida albicans and an Indirect Target of Lipopeptide Antimycotics
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Growth-subinhibitory nonlytic doses of cilofungin (lipopeptide antibiotic affecting (1,3)-beta-D-glucan synthesis) inhibited the incorporation of 46- to 48-kDa glucan-associated (46K) protein into the growing cell wall of Candida albicans. The purified 46K protein constituent strongly reacted with a monoclonal antibody against enolase, a major cytoplasmic enzyme of the fungus. In addition, two internal fragments of 12- and 15-amino acid residues from a tryptic digest of 46K protein showed 100% identity with amino acids in positions 34-45 and 66-80 of enolase. By immunoelectron microscopy with polyclonal and monoclonal anti-enolase antibodies, the 46K protein was clearly detected in the inner layers of the fungal cell wall. Thus, consistent with the proposed immunogenic and diagnostic roles of enolase in candidiasis, biochemical, immunochemical, and ultrastructural evidence strongly suggest that the cilofungin-susceptible 46K protein is a cell wall-associated form of this enzyme.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compounds active against cell walls of medically important fungi
Hector, R. F. (1993) · Clinical Microbiology Reviews · doi:10.1128/cmr.6.1.1 · Cited by 242 · cited 1×
“their potentially elevated selective toxicity and cytocidal mode of action [1-3].”
BackgroundCell Envelope of Candida Albicans
Shepherd, M. G. (1987) · CRC Critical Reviews in Microbiology · doi:10.3109/10408418709104445 · Cited by 137 · cited 2×
“candin-derived lipopeptide antifungals is the inhibition of synthesis of (l,3)-^-D-glucan, a major component of yeast cell wall [4, 15, 31, 32].”
Background
Cited by
The structure and synthesis of the fungal cell wall
Bowman, S. M., & Free, S. J. (2006) · BioEssays · doi:10.1002/bies.20441 · Cited by 1,317
Multifunctional α-enolase: its role in diseases
Pancholi, V. (2001) · Cellular and Molecular Life Sciences · doi:10.1007/pl00000910 · Cited by 838
Cell Wall and Secreted Proteins of Candida albicans: Identification, Function, and Expression
Chaffin, W. L., López-Ribot, J. L., Casanova, M., Gozalbo, D., & Martínez, J. P. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.1.130-180.1998 · Cited by 726
α-Enolase, a Novel Strong Plasmin(ogen) Binding Protein on the Surface of Pathogenic Streptococci
Pancholi, V., & Fischetti, V. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14503 · Cited by 553
Groll, A. H., Piscitelli, S. C., & Walsh, T. J. (1998) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60129-5 · Cited by 377
Metadata
- Authors
- Angiolella, L., Facchin, M., Stringaro, A., Maras, B., Simonetti, N., & Cassone, A.
- Venue
- Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1996-03-01
- Volume
- 173
- Issue
- 3
- Pages
- 684-690
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2122567752
- Cited by
- 129
- References
- 2
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Identification of a Glucan-Associated Enolase as a Main Cell Wall Protein of Candida albicans and an Indirect Target of Lipopeptide Antimycotics. https://app.cochat.ai/papers/10.1093/infdis/173.3.684
- The paper
- Angiolella, L., Facchin, M., Stringaro, A., Maras, B., Simonetti, N., & Cassone, A. (1996). Identification of a Glucan-Associated Enolase as a Main Cell Wall Protein of Candida albicans and an Indirect Target of Lipopeptide Antimycotics. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/173.3.684
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.